Diversity of extended-spectrum and plasmid-mediated AmpC β-lactamases in Enterobacteriaceae isolates from portuguese health care facilities

Journal of Microbiology

Volumn 52, Issue 6, 2014, Pages 496-503

  Jones Dias, Daniela ^a   Manageiro, Vera ^a   Ferreira, Eugénia ^a   Louro, Deolinda ^a   Caniça, Manuela ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

diversity; ESBL; health care facilities; PMA

Indexed keywords

AMPC BETA-LACTAMASES; BACTERIAL PROTEIN; BETA LACTAMASE;

ENTEROBACTERIACEAE; ENZYMOLOGY; GENETICS; HEALTH CARE FACILITY; HUMAN; ISOLATION AND PURIFICATION; PLASMID; PORTUGAL;

BACTERIAL PROTEINS; BETA-LACTAMASES; ENTEROBACTERIACEAE; HEALTH FACILITIES; HUMANS; PLASMIDS; PORTUGAL;

EID: 84901623340     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-014-3420-x     Document Type: Article

References (39)

1. CMY-2-mediated cephalosporin resistance in a multiresistant Salmonella enterica serovar Heidelberg isolate stemming from the importation of a boar by Denmark from Canada. Antimicrob. Agents Chemother. 48, 1916-1917.
2. Adriaenssens N., Coenen S., Versporten A., Muller A., Vankerckhoven V., Goossens H., and Group E. P. 2011. European surveillance of antimicrobial consumption (ESAC): Quality appraisal of antibiotic use in europe. J. Antimicrob. Chemother. 66 Suppl 6, vi71-77.
3. Alouache S., Estepa V., Messai Y., Ruiz E., Torres C., and Bakour R. 2013. Characterization of ESBLs and associated quinolone resistance in Escherichia coli and Klebsiella pneumoniae isolates from an urban wastewater treatment plant in Algeria. Microb. Drug Resist. 20, 30-38.
4. st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14, 933-951.
5. Briales A., Rodríguez-Martínez J. M., Velasco C., de Alba P. D., Rodríguez-Baño J., Martínez-Martínez L., and Pascual A. 2012. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6′)-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Int. J. Antimicrob. Agents39, 431-434.
6. CMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids. Antimicrob. Agents Chemother. 54, 590-596.
7. Cambray G., Guerout A. M., and Mazel D. 2010. Integrons. Annu. Rev. Genet. 44, 141-166.
8. Caniça M. M., Barthélémy M., Gilly L., Labia R., Krishnamoorthy R., and Paul G. 1997. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type β-lactamases. Antimicrob. Agents Chemother. 41, 374-378.
9. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K. L., and Threlfall E. J. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods63, 219-228.
10. Castanheira M., Mendes R. E., Woosley L. N., and Jones R. N. 2011. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: Report from the sentry antimicrobial surveillance programme (2007-09). J. Antimicrob. Chemother. 66, 1409-1411.
11. D'Andrea M. M., Arena F., Pallecchia L., and Rossolini G. M. 2013. CTX-M-type β-lactamases: A successful story of antibiotic resistance. Int. J. Med. Microbiol. 303, 305-317.
12. EARS-Net. 2012. Antimicrobial resistance surveillance in Europe 2011. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
13. Freitas F., Machado E., Ribeiro T. G., Novais A., and Peixe L. 2013. Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings. Eur. J. Clin. Microbiol. Infect. Dis. doi: 10. 1007/s10096-013-1983-9.
14. Grundmann H., Livermore D. M., Giske C. G., Canton R., Rossolini G. M., Campos J., Vatopoulos A., Gniadkowski M., Toth A., Pfeifer Y., andet al. 2010. Carbapenem-non-susceptible Enterobacteriaceae in Europe: Conclusions from a meeting of national experts. Euro Surveill. 15.
15. IMP-4 in a Klebsiella pneumoniae strain is closely related to other multidrug-resistant IncA/C2 plasmids. Curr. Microbiol. doi: 10. 1007/s00284-013-0471-x.
16. Jacoby G. A. 2009. Ampc β-lactamases. Clin. Microbiol. Rev. 22, 161-182.
17. Jones-Dias D., Manageiro V., Francisco A. P., Martins A. P., Domingues G., Louro D., Ferreira E., and Caniça M. 2013. Assessing the molecular basis of transferable quinolone resistance in Escherichia coli and Salmonella spp. from food producing animals and food products. Vet. Microbiol. doi: 265 10. 1016/j. vetmic. 2013. 08. 010.
18. CMY-2 β-lactamase gene in Escherichia coli and Salmonella enterica plasmids. Antimicrob. Agents Chemother. 50, 1590-1593.
19. Leverstein-van Hall M. A., Box A. T., Blok H. E., Paauw A., Fluit A. C., and Verhoef J. 2002. Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting. J. Infect. Dis. 186, 49-56.
20. Livermore D. M. 2009. β-Lactamases-the threat renews. Curr. Protein Pept. Sci. 10, 397-400.
21. Livermore D. M., Canton R., Gniadkowski M., Nordmann P., Rossolini G. M., Arlet G., Ayala J., Coque T. M., Kern-Zdanowicz I., Luzzaro F., andet al. 2007. CTX-M: Changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59, 165-174.
22. Machado E., Coque T. M., Cantón R., Baquero F., Sousa J. C., Peixe L., and the Portuguese Resistance Study Group. 2006. Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6′)-ib-cr gene, which encodes an aminoglycoside-and fluoroquinolonemodifying enzyme. Antimicrob. Agents Chemother. 50, 3220-3221.
23. Maltezou H. C., Giakkoupi P., Maragos A., Bolikas M., Raftopoulos V., Papahatzaki H., Vrouhos G., Liakou V., and Vatopoulos A. C. 2009. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J. Infect. 58, 213-219.
24. Manageiro V., Ferreira E., Jones-Dias D., Louro D., Pinto M., Diogo J., and Caniça M. 2012. Emergence and risk factors of β-lactamase-mediated resistance to oxyimino-β-lactams in Enterobacteriaceae isolates. Diagn. Microbiol. Infect. Dis. 72, 272-277.
25. Mata C., Miró E., Alvarado A., Garcillán-Barcia M. P., Toleman M., Walsh T. R., de la Cruz F., and Navarro F. 2012. Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampc genes: Findings from a spanish hospital 1999-2007. J. Antimicrob. Chemother. 67, 115-122.
26. DHA-1 and qnrB genes carried by broad-host-range plasmids among isolates of Enterobacteriaceae at a spanish hospital. Clin. Microbiol. Infect. 17, 1514-1517.
27. Mendonça N., Ferreira E., Louro D., ARSIP Participants, and Caniça M. 2009. Molecular epidemiology and antimicrobial susceptibility of extended-and broad-spectrum β-lactamaseproducing Klebsiella pneumoniae isolated in Portugal. Int. J. Antimicrob. Agents34, 29-37.
28. Mendonça N., Leitão J., Manageiro V., Ferreira E., and Caniça M. 2007. Spread of extended-spectrum β-lactamase CTX-Mproducing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob. Agents Chemother. 51, 1946-1955.
29. Mendonça N., Louro D., Castro A. P., Diogo J., and Caniça M. 2006. CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two portuguese regions. J. Antimicrob. Chemother. 57, 1014-1016.
30. Nicolas-Chanoine M. H., Blanco J., Leflon-Guibout V., Demarty R., Alonso M. P., Caniça M. M., Park Y. J., Lavigne J., Pitout J., and Johnson J. R. 2008. Intercontinental emergence of Escherichia coli clone O25: H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61, 273-281.
31. Patel G. and Bonomo R. A. 2011. Status report on carbapenemases: Challenges and prospects. Expert. Rev. Anti. Infect. Ther. 9, 555-570.
32. Paterson D. L. and Bonomo R. A. 2005. Extended-spectrum β-lactamases: A clinical update. Clin. Microbiol. Rev. 18, 657-686.
33. Philippon A., Arlet G., and Jacoby G. A. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46, 1-11.
34. Queenan A. M. and Bush K. 2007. Carbapenemases: The versatile β-lactamases. Clin. Microbiol. Rev. 20, 440-458.
35. Robicsek A., Strahilevitz J., Jacoby G. A., Macielag M., Abbanat D., Park C. H., Bush K., and Hooper D. C. 2006. Fluoroquinolonemodifying enzyme: A new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12, 83-88.
36. Silva-Sánchez J., Cruz-Trujillo E., Barrios H., Reyna-Flores F., Sánchez-Pérez A.; Bacterial Resistance Consortium, and Garza-Ramos U. 2013. Characterization of plasmid-mediated quinolone resistance (PMQR) genes in extended-spectrum β-lactamase-producing Enterobacteriaceae pediatric clinical isolates in Mexico. PLoS ONE8, e77968.
37. Toleman M. A. and Walsh T. R. 2011. Combinatorial events of insertion sequences and ICE in Gram-negative bacteria. FEMS Microbiol. Rev. 35, 912-935.
38. Verdet C., Benzerara Y., Gautier V., Adam O., Ould-Hocine Z., and Arlet G. 2006. Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: Genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob. Agents Chemother. 50, 607-617.
39. Yano H., Uemura M., Endo S., Kanamori H., Inomata S., Kakuta R., Ichimura S., Ogawa M., Shimojima M., Ishibashi N., andet al. 2013. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital. PLoS ONE8, e64359.